Mocertatug rezetecan clinical trials
3 indexed studies · 3 currently recruiting
- RecruitingPHASE3
A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)
This study is looking at a new medicine called Mocertatug Rezetecan (Mo-Rez) for women with ovarian cancer that hasn't responded well to previous platinum-based treatments. It aims to see if Mo-Rez works better or is safer than current standard treatments. It's a key step in understanding this new option.
For: Ovarian NeoplasmsAustralia · Canada · Japan - RecruitingPHASE1
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
This study is looking at a new medicine called GSK5733584 for people with advanced solid tumours. It aims to see if the treatment is safe, how well the body handles it, and how much of the medicine is in the body over time at different doses.
For: Solid Tumors · NeoplasmsUnited States · Argentina · Australia - RecruitingPHASE3
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
This study looks at a new drug, mocertatug rezetecan (Mo-Rez), for womb cancer that has come back after standard treatments. Researchers want to see if Mo-Rez works better and is safer than chemotherapy for people who have already tried other medicines for their cancer.
For: Neoplasms, EndometrialUnited States · Argentina · Australia